Viatris (VTRS) Free Cash Flow (2019 - 2026)
Viatris (VTRS) posted quarterly Free Cash Flow of $348.4 million for Q1 2026, down 29.32% year-over-year from $492.9 million in Q1 2025, and down 43.74% quarter-over-quarter from $619.3 million in Q4 2025.
Viatris (VTRS) Free Cash Flow (2019 - 2026) Analysis & Trends
Viatris' Free Cash Flow history runs 8 years deep, the most recent figure standing at $348.4 million for Q1 2026.
- In Q1 2026, Free Cash Flow fell 29.32% year-over-year to $348.4 million; the TTM figure through Mar 2026 stood at $1.8 billion (down 5.9% YoY), while the FY2025 annual figure was $1.9 billion, down 2.01% from the prior year.
- Free Cash Flow for Q1 2026 stood at $348.4 million, down from $619.3 million in the prior quarter.
- The five-year high for Free Cash Flow was $1.1 billion in Q1 2022, with the low at $35.3 million in Q4 2022.
- The 5-year median for Free Cash Flow is $564.8 million (2024), against an average of $551.7 million.
- The sharpest annual moves came in 2022 and 2023: Free Cash Flow plunged 89.16% in 2022, then jumped 1041.64% in 2023.
- Viatris' Free Cash Flow stood at $35.3 million in 2022, then surged by 1041.64% to $403.0 million in 2023, then slipped by 15.06% to $342.3 million in 2024, then soared by 80.92% to $619.3 million in 2025, then tumbled by 43.74% to $348.4 million in 2026.
- Business Quant data shows VTRS's Free Cash Flow at $348.4 million in Q1 2026, $619.3 million in Q4 2025, and $658.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 307.00 Mn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 538.00 Mn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 1.14 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 205.60 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 329.00 Mn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 128.60 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 244.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Alkermes | 8.14 Bn | 7.48 Bn | 397.90 Mn | 137.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 329.00 Mn |
| Jun 30, 2026 | 329.00 Mn |
| Mar 31, 2026 | 348.40 Mn |
| Mar 31, 2026 | 348.40 Mn |
| Dec 31, 2025 | 619.30 Mn |
| Dec 31, 2025 | 619.30 Mn |
| Sep 30, 2025 | 658.10 Mn |
| Sep 30, 2025 | 658.10 Mn |
| Jun 30, 2025 | 166.80 Mn |
| Jun 30, 2025 | 166.80 Mn |
| Mar 31, 2025 | 492.90 Mn |
| Mar 31, 2025 | 492.90 Mn |
| Dec 31, 2024 | 342.30 Mn |
| Dec 31, 2024 | 342.30 Mn |
| Sep 30, 2024 | 749.50 Mn |
| Sep 30, 2024 | 749.50 Mn |
| Jun 30, 2024 | 320.30 Mn |
| Jun 30, 2024 | 320.30 Mn |
| Mar 31, 2024 | 564.80 Mn |
| Mar 31, 2024 | 564.80 Mn |